NanoString Technologies Inc (NSTG) – Product Pipeline Analysis, 2017 Update

NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company NanoString Technologies Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Companies mentioned

miRagen Therapeutics Inc

Genomic Health Inc

Fluidigm Corp

Bio-Rad Laboratories Inc

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

NanoString Technologies Inc Company Overview 5

NanoString Technologies Inc Company Snapshot 5

NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5

NanoString Technologies Inc – Pipeline Analysis Overview 8

NanoString Technologies Inc – Key Facts 8

NanoString Technologies Inc – Major Products and Services 9

NanoString Technologies Inc Pipeline Products by Development Stage 10

NanoString Technologies Inc Pipeline Products Overview 12

Advanced Gene Expression Assay 12

Advanced Gene Expression Assay Product Overview 12

Companion Diagnostic Assay – Diffuse Large B-Cell Lymphoma (DLBCL) 13

Companion Diagnostic Assay – Diffuse Large B-Cell Lymphoma (DLBCL) Product Overview 13

Companion Diagnostic Test – Enzalutamide 14

Companion Diagnostic Test – Enzalutamide Product Overview 14

Digital Immunohistochemistry Device 15

Digital Immunohistochemistry Device Product Overview 15

Immune-Related Gene Expression Assay 16

Immune-Related Gene Expression Assay Product Overview 16

In Vitro Diagnostic Assay – HCC Gene Signature 17

In Vitro Diagnostic Assay – HCC Gene Signature Product Overview 17

Multi-Omic Assay 18

Multi-Omic Assay Product Overview 18

nCounter Vantage DNA Solid Tumor Panel 19

nCounter Vantage DNA Solid Tumor Panel Product Overview 19

nCounter Vantage RNA:Protein Solid Tumor Pathways Panel 20

nCounter Vantage RNA:Protein Solid Tumor Pathways Panel Product Overview 20

NanoString Technologies Inc – Key Competitors 21

NanoString Technologies Inc – Key Employees 22

NanoString Technologies Inc – Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

NanoString Technologies Inc, Recent Developments 24

May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 24

Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 25

Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 26

Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 27

Jan 31, 2017: Humana Issues Positive Coverage Decision for NanoString's Prosigna Breast Cancer Assay 28

Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 29

Jan 10, 2017: Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment for NanoString's Prosigna Breast Cancer Assay 29

Dec 12, 2016: Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of TransATAC Study Presented at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 30

Dec 05, 2016: NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 32

Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples 35

Appendix 36

Methodology 36

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Tables

List of Tables

NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5

NanoString Technologies Inc Pipeline Products by Equipment Type 6

NanoString Technologies Inc Pipeline Products by Indication 7

NanoString Technologies Inc, Key Facts 8

NanoString Technologies Inc, Major Products and Services 9

NanoString Technologies Inc Number of Pipeline Products by Development Stage 10

NanoString Technologies Inc Pipeline Products Summary by Development Stage 11

Advanced Gene Expression Assay – Product Status 12

Advanced Gene Expression Assay – Product Description 12

Companion Diagnostic Assay – Diffuse Large B-Cell Lymphoma (DLBCL) – Product Status 13

Companion Diagnostic Assay – Diffuse Large B-Cell Lymphoma (DLBCL) – Product Description 13

Companion Diagnostic Test – Enzalutamide – Product Status 14

Companion Diagnostic Test – Enzalutamide – Product Description 14

Digital Immunohistochemistry Device – Product Status 15

Digital Immunohistochemistry Device – Product Description 15

Immune-Related Gene Expression Assay – Product Status 16

Immune-Related Gene Expression Assay – Product Description 16

In Vitro Diagnostic Assay – HCC Gene Signature – Product Status 17

In Vitro Diagnostic Assay – HCC Gene Signature – Product Description 17

Multi-Omic Assay – Product Status 18

Multi-Omic Assay – Product Description 18

nCounter Vantage DNA Solid Tumor Panel – Product Status 19

nCounter Vantage DNA Solid Tumor Panel – Product Description 19

nCounter Vantage RNA:Protein Solid Tumor Pathways Panel – Product Status 20

nCounter Vantage RNA:Protein Solid Tumor Pathways Panel – Product Description 20

NanoString Technologies Inc, Key Employees 22

Glossary 37

List of Figures

List of Figures

NanoString Technologies Inc Pipeline Products by Equipment Type 6

NanoString Technologies Inc Pipeline Products by Development Stage 10

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports